We are live on ! Find out more
IA

Investor AB Portfolio holdings

AUM $15.1B
1-Year Est. Return 29.02%
This Fund
S&P 500
This Quarter Est. Return
-0.95%
1 Year Est. Return
+29.02%
3 Year Est. Return
+79.02%
5 Year Est. Return
+98.76%
10 Year Est. Return
+341.52%
AUM
$1.51B
AUM Growth
-$38M
Cap. Flow
-$19M
Cap. Flow %
-1.26%
Top 10 Hldgs %
100%
Holding
10
New
2
Increased
–
Reduced
2
Closed
3

Top Buys

Rank Stock Value
1
HAL icon
Halliburton
HAL
+$882K
2
SLB icon
SLB Ltd
SLB
+$648K

Top Sells

Rank Stock Value
1
CORT icon
Corcept Therapeutics
CORT
+$14.5M
2
ALV icon
Autoliv
ALV
+$4.94M
3
SRCL
Stericycle Inc
SRCL
+$716K
4
CG icon
Carlyle Group
CG
+$282K
5
CCIH
Chinacache International Holdings Ltd
CCIH
+$147K

Sector Composition

Rank Sector Weight
1 Financials 98.49%
2 Technology 0.3%
3 Energy 0.11%
4 Consumer Discretionary 0%
5 Healthcare 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NDAQ icon
1
Nasdaq
NDAQ
$53.4B
$1.49B 98.47%
58,182,426
– –
AGRX
2
DELISTED
Agile Therapeutics
AGRX
$9.44M 0.62%
1,755
– –
MATR
3
DELISTED
Mattersight Corp.
MATR
$7.24M 0.48%
2,838,557
– –
CCIH
4
DELISTED
Chinacache International Holdings Ltd
CCIH
$4.48M 0.3%
2,649,443
-126,049
-5% -$147K
HAL icon
5
Halliburton
HAL
$26.1B
$977K 0.06%
+20,000
New +$882K
SLB icon
6
SLB Ltd
SLB
$72.7B
$674K 0.04%
+10,000
New +$648K
CG icon
7
Carlyle Group
CG
$16.1B
$275K 0.02%
12,000
-12,600
-51% -$282K
ALV icon
8
Autoliv
ALV
$9.14B
– –
-55,520
Closed -$4.94M
CORT icon
9
Corcept Therapeutics
CORT
$9.98B
– –
-750,423
Closed -$14.5M
SRCL
10
DELISTED
Stericycle Inc
SRCL
– –
-10,000
Closed -$716K

Similar funds

MSV
MN Services Vermogensbeheer The Hague, Netherlands $15.1B AUM 26.53% 1-Year Est. Return
AT
AMF Tjänstepension Stockholm, Sweden $15.1B AUM 30.1% 1-Year Est. Return
UM
UniSuper Management Melbourne, Victoria, Australia $15.3B AUM 29.4% 1-Year Est. Return
RFC
Regions Financial Corp Birmingham, Alabama $15.4B AUM 21.7% 1-Year Est. Return
FCAS
First Command Advisory Services Fort Worth, Texas $14.8B AUM 18.11% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return
Mawer Investment Management
Mawer Investment Management Calgary, Alberta, Canada $15.4B AUM 10.9% 1-Year Est. Return

Investor AB's Q4 2017 Portfolio in Review

As of Q4 2017, Investor AB held 10 positions worth $1.51B, down 2.4% from $1.55B the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Investor AB's Q4 2017 filing shows 2 new, 2 reduced and 3 closed positions. Its largest new stake was Halliburton: 20,000 shares worth $977K. The largest sale was Corcept Therapeutics, an estimated $14.5M.

By sector, the portfolio is most concentrated in Financials at 98% of assets, up from 97% a quarter earlier, followed by Technology and Energy.

  • Investor AB's largest Q4 2017 buy was Halliburton: 20,000 shares worth $977K.
  • Investor AB's biggest Q4 2017 reduction was Carlyle Group, cutting an estimated $282K.
  • Investor AB fully exited Corcept Therapeutics in Q4 2017, selling an estimated $14.5M.
  • Investor AB's ten largest holdings make up 100% of its $1.51B portfolio in Q4 2017.
  • Investor AB opened 2 new positions and closed 3 in Q4 2017.
  • Investor AB's portfolio value fell 2.4% quarter-over-quarter to $1.51B.

Based on Investor AB's 13F filing for Q4 2017, filed 14 Feb 2018.